BJDX Bluejay Diagnostics, Inc.
0.8101USD-0.07%Mkt Cap: 3.62M $P/E: —1d ago
Bluejay Diagnostics, Inc. operates as a medical diagnostics company. It offers Symphony technology platform which consists of an analyzer and single-use protein detection cartridges that are designed to provide measureme…
Industry Peers
Medical Devices$171.97BUSDP/E 31.8
$109.38BUSDP/E 21.0
$105.64BUSDP/E 28.5
$60.26BUSDP/E 16.8
$49.39BUSDP/E 51.1
$46.91BUSDP/E 19.6
$31.81BUSDP/E 33.5
$29.42BUSDP/E 14.9
$23.55BUSDP/E 18.0
$22.87BUSDP/E 18.7
$20.44BUSDP/E 25.6
$17.11BUSDP/E 28.0
$16.88BUSDP/E 21.5
$12.46BUSDP/E 77.7
$11.25BUSDP/E 18.3
$10.16BUSD
$9.87BUSDP/E 28.0
$9.92BUSD
$9.90BUSDP/E 18.9
$9.85BUSDP/E 46.6
| Headline | Source | Time |
|---|---|---|
Older | ||
 Bluejay Diagnostics Federal Healthcare Partnership Builds Commercial Pathway Ahead of FDA Clearance The Lovell Government Services agreement establishes federal procurement infrastructure for the Symphony platform, but commercialization remains dependent on regulatory authorization. Key Investor TakeawaysBluejay Diagnostics (NASDAQ:BJDX) has formed a distribution, co-marketing and strategic partnership with Lovell Government Services targeting U. | ||